---
schema_version: "secwatch.filing_event.v1"
accession: "0000072331-25-000074"
form_type: "8-K/A"
ticker: "NDSN"
cik: "0000072331"
company_name: "NORDSON CORP"
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T14:29:03.387300+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nordson separation agreement for departing segment leader Lovass: $832,759 cash, continued vesting

## Summary
- Stephen Lovass ceased as Medical and Fluid Solutions segment leader; assists transition until June 1, 2025, then separates.
- Receives $832,759 cash (severance plus COBRA) and pro-rata FY2025 annual incentive under separation agreement.
- Stock options granted on/before Dec 1, 2022 continue vesting; exercisable until June 1, 2030 or original expiry.
- Restricted shares/units from same period vest pro-rata; PSUs from Dec 1, 2022 vest pro-rata based on actual performance.
- One-year non-compete, non-solicitation; indefinite confidentiality, non-disparagement; outplacement up to $10k, financial planning up to $5k.

## SEC filing metadata
- accession: 0000072331-25-000074
- form_type: 8-K/A
- ticker: NDSN
- cik: 0000072331
- company_name: NORDSON CORP
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72331/000007233125000074/0000072331-25-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72331/000007233125000074/ndsn-20250428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000072331-25-000074
- JSON: https://secwatch.observer/filing/0000072331-25-000074.json
- Plain text: https://secwatch.observer/filing/0000072331-25-000074.txt

## Key facts
- Executive change
  Stephen Lovass departed as segment leader for the Medical and Fluid Solutions Segment at NORDSON CORP.
  - Action: ceased to serve
  - Role: segment leader for the Medical and Fluid Solutions Segment
  source text: the Original Form 8-K reported that, on April 28, 2025, Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/72331/000007233125000074/0000072331-25-000074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.